Oscar Health (NYSE:OSCR) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Oscar Health (NYSE:OSCR) from a sell rating to a hold rating in a research note issued to investors on Saturday morning.

OSCR has been the topic of several other research reports. Raymond James Financial upgraded Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 price target on the stock in a research note on Thursday. Barclays set a $18.00 target price on shares of Oscar Health and gave the company an “equal weight” rating in a research report on Monday, January 5th. UBS Group reaffirmed a “neutral” rating and issued a $15.00 price target on shares of Oscar Health in a research report on Wednesday, February 11th. Wells Fargo & Company dropped their price objective on shares of Oscar Health from $14.00 to $11.00 and set an “underweight” rating on the stock in a research note on Thursday, November 13th. Finally, Piper Sandler raised shares of Oscar Health from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $13.00 to $25.00 in a research note on Tuesday, November 25th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $16.88.

Oscar Health Stock Performance

Oscar Health stock opened at $13.41 on Friday. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.92 and a current ratio of 0.92. The company has a market capitalization of $3.55 billion, a PE ratio of -7.70 and a beta of 1.90. The company has a 50 day moving average price of $15.17 and a 200-day moving average price of $16.72. Oscar Health has a fifty-two week low of $11.20 and a fifty-two week high of $23.80.

Oscar Health (NYSE:OSCR) last released its quarterly earnings data on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing the consensus estimate of ($0.92) by ($0.32). The firm had revenue of $2.76 billion for the quarter, compared to analysts’ expectations of $3.12 billion. Oscar Health had a negative return on equity of 37.72% and a negative net margin of 3.79%.The company’s revenue for the quarter was up 17.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.62) earnings per share. As a group, equities analysts forecast that Oscar Health will post 0.69 earnings per share for the current year.

Insider Activity

In other news, insider Janet Liang sold 7,338 shares of the company’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $121,737.42. Following the transaction, the insider directly owned 172,527 shares of the company’s stock, valued at approximately $2,862,222.93. This represents a 4.08% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Richard Scott Blackley sold 25,135 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total value of $416,989.65. Following the completion of the sale, the chief financial officer directly owned 1,351,034 shares of the company’s stock, valued at $22,413,654.06. The trade was a 1.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 197,125 shares of company stock valued at $3,265,300 over the last three months. Company insiders own 25.11% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

Several institutional investors have recently added to or reduced their stakes in OSCR. Farther Finance Advisors LLC raised its position in shares of Oscar Health by 4,420.7% in the 3rd quarter. Farther Finance Advisors LLC now owns 1,311 shares of the company’s stock valued at $25,000 after purchasing an additional 1,282 shares during the last quarter. Atlantic Union Bankshares Corp purchased a new stake in Oscar Health during the 2nd quarter worth approximately $33,000. Quarry LP increased its stake in Oscar Health by 439.8% during the 3rd quarter. Quarry LP now owns 1,803 shares of the company’s stock valued at $34,000 after purchasing an additional 1,469 shares in the last quarter. Tsfg LLC purchased a new position in shares of Oscar Health in the third quarter worth $38,000. Finally, Jones Financial Companies Lllp lifted its stake in shares of Oscar Health by 7,473.3% during the first quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock worth $30,000 after buying an additional 2,242 shares during the period. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.